Therefore, although our results indicate significant differences only in the PYCR1 isoform, it would seem appropriate to refrain from definite conclusions dismissing the role of PYCR2 and PYCR3 in gliomas until the wider context of the multi-layered metabolic network involved is better understood. This evidence concerns the gene PYCR1 and central nervous system cancer.